IP Library Granted Patent US 10,406,260
Granted Patent B2
US 10,406,260 · App. 15/176,863 · Granted Sep 10, 2019

Acellular tissue matrix composition for tissue repair

Inventors: Rick T. Owens (Stewartsville, NJ); Wendell Sun (Warrington, PA)
Assignee: LifeCell Corporation
A61L27/362A61L27/16A61L27/18A61L27/36A61L27/3633A61L31/005C08L89/06A61L2400/18A61L2420/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,406,260
App. No.
15/176,863
Granted
Sep 10, 2019
Kind
B2
Abstract

The invention provides tissue repair compositions and methods of making the tissue repair compositions. Also featured are methods of treatment using the tissue repair compositions and articles of manufacture that include the tissue repair compositions.

Claims (10)

1. A biocompatible implant composition, comprising: a polypropylene sheet substrate; and a biocompatible coating surrounding the sheet substrate, wherein the coating comprises a dried group of particulate acellular tissue matrix (ATM) particles, wherein the ATM particles comprise intact ATM swollen in an acidic solution having a pH of from about 1.0 to about 3.0 and that retains biological functions provided by undenatured collagenous proteins and non-collagenous molecules, wherein the instant ATM is swollen to a volume ranging from 1.8 to 12 times the initial volume of the ATM.

2. The implant composition of claim 1 , wherein the ATM comprises dermal ATM.

3. The implant composition of claim 1 , wherein the ATM comprises ATM derived from at least one of fascia, pericardial tissue, dura, umbilical cord tissue, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, and intestinal tissue.

4. The implant composition of claim 1 , wherein the ATM is derived from human tissue.

5. The implant composition of claim 1 , wherein the ATM is derived from non-human mammalian tissue.

6. The implant composition of claim 1 , wherein the non-human mammalian tissue is porcine.

7. The implant composition of claim 6 , wherein the tissue is from a non-human mammal that is genetically engineered to lack expression of α-1,3-galactosyl epitopes.

8. The implant composition of claim 7 , wherein the non-human mammal lacks a functional α-1,3-galactosyltransferase gene.

9. The implant composition of claim 1 , wherein the polypropylene sheet is a mesh.

10. The implant of claim 8 , wherein the polypropylene sheet comprises polypropylene monofilament.

Assignments (6)
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2016
From: OWENS, RICK T.; SUN, WENDELL
To: LIFECELL CORPORATION
Reel/Frame 038853/0636 →
Continuity (3)
Continuation 12747441
Provisional Application 60948793 · Jul 10, 2007
Related Publication 20160317707A1 · Nov 3, 2016